Pregnancy and cardiovascular risk: A review focused on women with heart disease undergoing fertility treatment
Nora Rossberg(Charité - Universitätsmedizin Berlin), Verena Stangl(Deutsches Herzzentrum der Charité), Karl Stangl(German Centre for Cardiovascular Research)
Cited by 32
Related Papers
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
|European Heart Journal|2017|334
A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation
|Journal of Biological Chemistry|2004|332
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
|European Heart Journal|2005|274
Molecular targets of tea polyphenols in the cardiovascular system
|Cardiovascular Research|2006|241